Rho Capital Partners

Latest statistics and disclosures from Rho Capital Partners's latest quarterly 13F-HR filing:

Companies in the Rho Capital Partners portfolio as of September 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Cara Therapeutics 76.92 3.57M 13.69
Mersana Therapeutics 22.27 818033 17.29
Senseonics Hldgs 0.80 159601 3.19

Past 13F-HR SEC Filings by Rho Capital Partners

View All Filings